Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Depression Drugs Market Size Olanzapine Market Size Premium Messaging Market Size Data Center Cooling Market SizeGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Size to Exceed USD 4.48 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size is Expected to Grow from USD 2.27 Billion in 2023 to USD 4.48 Billion by 2033, at a CAGR of 7.03 during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, Share, and COVID-19 Impact Analysis, By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), By Technology (Chemiluminescent, Colorimetric, and Fluorescent), By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry, and Transplantation), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The enzyme-linked immunosorbent assay (ELISA) market indicates the worldwide market involved in ELISA-based research and diagnostic kit development, manufacture, and marketing. ELISA is a biochemistry method utilized to identify and measure proteins, antibodies, hormones, and other molecules in biospecimens. The market incorporates different types of ELISA, such as direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA, with applications in health care, pharmacy, biotech, food quality, and ecology. Growth within this market is fueled by rising disease diagnostics, growing demand for personalized medicine, and technological improvements in immunoassay technologies. Furthermore, the ELISA market is driven by the rising prevalence of infectious and chronic diseases, increasing demand for diagnostic solutions, advancements in biotechnology, and growing research in drug development. Additionally, expanding applications in food safety, environmental monitoring, and veterinary diagnostics, along with technological innovations enhancing assay sensitivity and automation, further propel market growth globally. However, the high costs, complex procedures, skilled workforce requirements, limited sensitivity compared to advanced techniques, regulatory challenges, lengthy approval processes, competition from alternative diagnostic methods, and supply chain disruptions are key restraints for the growth of the market.
The indirect ELISA segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the method, the global enzyme-linked immunosorbent assay (ELISA) market is divided into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. Among these, the indirect ELISA segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to its high sensitivity, cost-effectiveness, and versatility in detecting antibodies for various diseases. Growth is driven by increasing applications in immunology, infectious disease diagnostics, and research, along with advancements in assay techniques enhancing accuracy and efficiency in clinical and pharmaceutical settings.
The colorimetric segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the technology, the global enzyme-linked immunosorbent assay (ELISA) market is divided into chemiluminescent, colorimetric, and fluorescent. Among these, the colorimetric segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to its cost-effectiveness, ease of use, and widespread adoption in research and diagnostics. Growth is driven by its high sensitivity, compatibility with standard lab equipment, and increasing demand for reliable ELISA-based detection methods in immunology, infectious diseases, and pharmaceutical applications.
The immunology segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.
On the basis of the application, the global enzyme-linked immunosorbent assay (ELISA) market is divided into vaccine development, immunology, diagnostics, toxicology, drug monitoring & pharmaceutical industry, and transplantation. Among these, the immunology segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to ELISA’s critical role in detecting antibodies, antigens, and proteins linked to autoimmune diseases, allergies, and infections. Growth is driven by rising immunological disorder prevalence, increasing research activities, advancements in diagnostic techniques, and the growing need for precise and early disease detection methods.
North America is projected to hold the largest share of the global enzyme-linked immunosorbent assay (ELISA) market over the forecast period.
North America is projected to hold the largest share of the global enzyme-linked immunosorbent assay (ELISA) market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, strong presence of key market players, and high R&D investments. Additionally, the increasing prevalence of infectious and autoimmune diseases, the rising demand for early disease diagnosis, favorable regulatory policies, and the widespread adoption of ELISA in research and clinical diagnostics drive market growth.
Asia Pacific is expected to grow at the fastest CAGR growth of the global enzyme-linked immunosorbent assay (ELISA) market during the forecast period. The regional growth is attributed to rising healthcare investments, increasing prevalence of infectious and autoimmune diseases, and expanding biotechnology and pharmaceutical industries. Additionally, growing awareness of early disease detection, improving healthcare infrastructure, government initiatives for diagnostic advancements, and increasing adoption of ELISA in research and clinical applications fuel market expansion.
Company Profiling
Major vendors in the global enzyme-linked immunosorbent assay (ELISA) market are Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd., and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global enzyme-linked immunosorbent assay (ELISA) market based on the below-mentioned segments:
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Method
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Technology
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Application
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Regional
May 2025 - The Global K-beauty Products Market Size is Expected to Grow from USD 9.02 Billion in 2023 to USD 15.13 Billion by 2033, at a CAGR of 5.31% during the forecast period 2023-2033
May 2025 - The Global Healthy Snacks Market Size is Expected to Grow from USD 94.62 Billion in 2023 to USD 173.12 Billion by 2033, at a CAGR of 6.23% during the forecast period 2023-2033
May 2025 - The Global Centrifugal Pump Market Size is Expected to Grow from USD 38.16 Billion in 2023 to USD 58.10 Billion by 2033, at a CAGR of 4.29% during the forecast period 2023-2033
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
